US Stock MarketDetailed Quotes
BFRI Biofrontera
- 1.2900
- +0.0600+4.88%
Close Sep 13 16:00 ET
- 1.2900
- 0.00000.00%
Post 20:02 ET
7.15MMarket Cap-470P/E (TTM)
1.3000High1.2200Low253.92KVolume1.2500Open1.2300Pre Close319.09KTurnover8.59%Turnover RatioLossP/E (Static)5.54MShares9.520052wk High0.66P/B3.81MFloat Cap0.610052wk Low--Dividend TTM2.96MShs Float292.6000Historical High--Div YieldTTM6.50%Amplitude0.6100Historical Low1.2560Avg Price1Lot Size
Biofrontera Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 34.05%7.84M | -9.40%7.91M | 18.82%34.07M | 4.46%10.6M | 105.83%8.9M | 31.21%5.85M | -10.44%8.73M | 18.98%28.67M | 10.65%10.14M | -0.28%4.32M |
| Operating revenue | 34.05%7.84M | -9.40%7.91M | 18.82%34.07M | 4.46%10.6M | 105.83%8.9M | 31.21%5.85M | -10.44%8.73M | 18.98%28.67M | 10.65%10.14M | -0.28%4.32M |
| Cost of revenue | 50.35%4.34M | -10.48%4.12M | 14.88%17.44M | 2.13%5.37M | 106.29%4.59M | 13.08%2.89M | -10.72%4.6M | 19.17%15.19M | 10.12%5.26M | -2.84%2.23M |
| Gross profit | 18.14%3.5M | -8.20%3.8M | 23.26%16.63M | 6.96%5.23M | 105.34%4.31M | 55.54%2.96M | -10.13%4.14M | 18.76%13.49M | 11.22%4.89M | 2.59%2.1M |
| Operating expense | -31.18%7.95M | -5.74%9.26M | 9.29%39.2M | -10.92%9.09M | 9.95%8.73M | 15.31%11.55M | 27.44%9.83M | -3.60%35.87M | 10.04%10.21M | -53.99%7.94M |
| Selling and administrative expenses | -31.18%7.95M | -5.91%9.25M | 9.08%39.13M | -11.25%9.06M | 9.54%8.69M | 15.31%11.55M | 27.44%9.83M | -3.60%35.87M | 10.04%10.21M | -53.99%7.94M |
| Research and development costs | ---- | --17K | --77K | --33K | --33K | ---- | --0 | --0 | --0 | --0 |
| Operating profit | 48.18%-4.45M | 3.95%-5.47M | -0.88%-22.58M | 27.35%-3.87M | 24.30%-4.42M | -5.87%-8.59M | -83.02%-5.69M | 13.42%-22.38M | -8.97%-5.32M | 61.60%-5.84M |
| Net non-operating interest income expense | -654.43%-596K | -3,920.00%-1.41M | -175.86%-560K | -606.98%-304K | -59.55%-142K | -107.89%-79K | -6.06%-35K | 40.99%-203K | 51.69%-43K | -3.49%-89K |
| Non-operating interest income | -42.86%24K | -75.00%14K | -24.57%132K | -63.16%21K | 333.33%13K | -22.22%42K | -6.67%56K | 993.75%175K | 1,800.00%57K | -25.00%3K |
| Non-operating interest expense | 412.40%620K | 1,461.54%1.42M | 62.16%600K | 153.26%233K | 68.48%155K | 31.52%121K | -2.15%91K | 2.78%370K | 0.00%92K | 2.22%92K |
| Total other finance cost | ---- | ---- | 1,050.00%92K | ---- | ---- | ---- | ---- | --8K | ---- | ---- |
| Other net income (expense) | 516.00%4.81M | -104.01%-3.56M | -86.26%3.02M | 198.14%7.69M | -152.90%-1.78M | -115.84%-1.16M | -119.99%-1.75M | 291.73%21.98M | 127.06%2.58M | 571.01%3.36M |
| Gain on sale of security | 589.97%5.42M | -79.09%-3.43M | -124.28%-4.4M | -91.62%238K | -236.20%-1.61M | -120.61%-1.11M | -121.96%-1.91M | 241.45%18.11M | --2.84M | --1.19M |
| Special income (charges) | -459.46%-621K | -258.00%-316K | 91.71%7.29M | 2,561.67%7.39M | -109.09%-200K | -105.84%-111K | --200K | 484.62%3.8M | -109.99%-300K | 344.72%2.2M |
| -Less：Restructuring and merger&acquisition | 459.46%621K | --0 | 102.63%100K | --0 | 109.09%200K | 105.84%111K | ---200K | -484.62%-3.8M | 109.99%300K | -344.72%-2.2M |
| -Less:Other special charges | ---- | --316K | ---7.39M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | -90.32%6K | 645.45%180K | 89.86%131K | 69.23%66K | 259.09%35K | 113.79%62K | -243.48%-33K | -89.99%69K | -85.56%39K | -111.89%-22K |
| Income before tax | 97.59%-237K | -39.65%-10.44M | -3,208.72%-20.12M | 226.44%3.52M | -147.21%-6.34M | -1,055.65%-9.82M | -233.66%-7.47M | 98.39%-608K | 80.80%-2.78M | 83.97%-2.57M |
| Income tax | 42.86%20K | -80.00%1K | -56.25%14K | -700.00%-6K | 0.00%1K | 14K | -83.33%5K | -42.86%32K | -80.00%1K | -83.33%1K |
| Net income | 97.39%-257K | -39.57%-10.44M | -3,045.47%-20.13M | 226.61%3.53M | -147.16%-6.34M | -1,057.29%-9.84M | -234.47%-7.48M | 98.30%-640K | 80.80%-2.79M | 83.97%-2.57M |
| Net income continuous Operations | 97.39%-257K | -39.57%-10.44M | -3,045.47%-20.13M | 226.61%3.53M | -147.16%-6.34M | -1,057.29%-9.84M | -234.47%-7.48M | 98.30%-640K | 80.80%-2.79M | 83.97%-2.57M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 97.39%-257K | -39.57%-10.44M | -3,045.47%-20.13M | 226.61%3.53M | -147.16%-6.34M | -1,057.29%-9.84M | -234.47%-7.48M | 98.30%-640K | 80.80%-2.79M | 83.97%-2.57M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 97.39%-257K | -39.57%-10.44M | -3,045.47%-20.13M | 226.61%3.53M | -147.16%-6.34M | -1,057.29%-9.84M | -234.47%-7.48M | 98.30%-640K | 80.80%-2.79M | 83.97%-2.57M |
| Basic earnings per share | 99.31%-0.05 | 48.57%-2.88 | -2,034.43%-13.02 | 318.10%4.55 | -105.31%-4.64 | -703.33%-7.23 | -184.85%-5.6 | 99.29%-0.61 | 91.91%-2.0862 | 92.24%-2.26 |
| Diluted earnings per share | 99.31%-0.05 | 48.57%-2.88 | -2,034.43%-13.02 | 318.10%4.55 | -105.31%-4.64 | -703.33%-7.23 | -187.50%-5.6 | 99.29%-0.61 | 91.91%-2.0862 | 92.24%-2.26 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data